Study of laboratory parameters in left ventricular diastolic dysfunction in patients with pulmonary arterial hypertension

 

 

REFERENCES

1. Rubin LJ: Primary pulmonary hypertension. N Engl J Med 1997, 336(2):111–7.
2. Simonneau G, et al: Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 2009, 54(1 Suppl):S43–54.
3. Wagenvoort CA, Wagenvoort N: Primary pulmonary hypertension: a pathological study of the lung vessels in 156 clinically diagnosed cases. Circulation 1970, 42:1163–84.
4. Hatano S, Strasser T: Primary Pulmonary Hypertension. Report on a WHO meeting. October 15–17, 1973. Geneva: WHO; 1975.
5. Fishman AP: Clinical classification of pulmonary hypertension. Clin Chest Med 2001, 22(3):385–91. vii.
6. B. Burrows, L. J. Kettel, A. H. Niden, M. Rabinowitz, and C. F. Diener, “Patterns of cardiovascular dysfunction in chronic obstructive lung disease,” The New England Journal of Medicine, vol. 286, no. 17, pp. 912–918, 1972.
7. E. Weitzenblum, A. Sautegeau, and M. Ehrhart, “Long-term course of pulmonary arterial pressure in chronic obstructive pulmonary disease,” The American Review of Respiratory Disease, vol. 130, no. 6, pp. 993–998, 1984.
8. M. Oswald-Mammosser, M. Apprill, P. Bachez, M. Ehrhart, and E.Weitzenblum, “Pulmonary hemodynamics in chronic obstructive pulmonary disease of the emphysematous type,” Respiration, vol. 58, no. 5-6, pp. 304–310, 1991.
9. S. M. Scharf, M. Iqbal, C. Keller et al., “Hemodynamic characterization of patients with severe emphysema,” American Journal of Respiratory and Critical CareMedicine, vol. 166, pp. 314–322, 2002.
10. G. Thabut, G. Dauriat, J. B. Stern et al., “Pulmonary hemodynamics in advanced COPD candidates for lung volume reduction surgery or lung transplantation,” Chest, vol. 127, no. 5, pp. 1531–1536, 2005.
11. M. J. Cuttica, R. Kalhan, O. A. Shlobin et al., “Categorization and impact of pulmonary hypertension in patients with advanced COPD,” Respiratory Medicine, vol. 104, no. 12, pp. 1877–1882, 2010.
12. E.Weitzenblum, “Chronic cor pulmonale,” Heart, vol. 89, no. 2, pp. 225–230, 2003.
13. J. R. Catterall, N. J. Douglas, and P. M. A. Calverley, “Transient hypoxemia during sleep in chronic obstructive pulmonary disease is not a sleep apnea syndrome,” The American Review of Respiratory Disease, vol. 128, no. 1, pp. 24–29, 1983. Pulmonary Medicine 13
14. E. C. Fletcher and D. C. Levin, “Cardiopulmonary hemodynamics during sleep in subjects with chronic obstructive pulmonary disease. The effect of short- and long-term oxygen,” Chest, vol. 85, no. 1, pp. 6–14, 1984.
15. G. Coccagna and E. Lugaresi, “Arterial blood gases and pulmonary and systemic arterial pressure during sleep in chronic obstructive pulmonary disease,” Sleep, vol. 1, no. 2, pp. 117–124, 1978.
16. A. S. Abraham, R. B. Cole, I. D. Green, R. B. Hedworth- Whitty, S.W. Clarke, and J.M. Bishop, “Factors contributing to the reversible pulmonary hypertension of patients with acute respiratory failure studies by serial observations during recovery,” Circulation Research, vol. 24, no. 1, pp. 51–60, 1969.
17. E. Weitzenblum, A. Loiseau, C. Hirth, R. Mirhom, and J. Rasaholinjanahary, “Course of pulmonary hemodynamics in patients with chronic obstructive pulmonary disease,” Chest, vol. 75, no. 6, pp. 656–662, 1979.
18. K. Kubo, R. L. Ge, T. Koizumi et al., “Pulmonary artery remodelling modifies pulmonary hypertension during exercise in severe emphysema,” Respiration Physiology, vol. 120, no. 1, pp. 71–79, 2000.
19. J. L. Wright, L. Lawson, P. D. Pare et al., “The structure and function of the pulmonary vasculature in mild chronic obstructive pulmonary disease. The effect of oxygen and exercise,” The American Review of Respiratory Disease, vol. 128, no. 4, pp. 702–707, 1983.
20. J. Butler, F. Schrijen, A. Henriquez, J. M. Polu, and R. K. Albert, “Cause of the raised wedge pressure on exercise in chronic obstructive pulmonary disease,” The American Review of Respiratory Disease, vol. 138, no. 2, pp. 350–354, 1988.
21. J. A. Barber`a and I. Blanco, “Pulmonary hypertension in patients with chronic obstructive pulmonary disease: advances in pathophysiology and management,” Drugs, vol. 69, no. 9, pp. 1153–1171, 2009.
22. Padity E, et al. ECHO diagnosis of pulmonary hypertension in chronic lung diseases. Phrenology 1992; 46: 131-140.
23. Schiller NB, Shah P,. Et al. Recommendations for quantization of left ventricle by two dimensional echocardiography. American Society of Echocardiography. J Am Soc Echocardiography 1989; 2: 358-367.
24. Rich S, Dantzker DR, Ayres SM, Bergofsky EH, Brundage BH, Detre KM, Fishman AP, Goldring RM, Groves BM, Koerner SK. Primary pulmonary hypertension. A national prospective study. Ann Intern Med 1987; 107: 216–223.
25. Tongers J, Schwerdtfeger B, Klein G, Kempf T, Schaefer A, Knapp JM, Niehaus M, Korte T, Hoeper MM. Incidence and clinical relevance of supraventricular tachyarrhythmias in pulmonary hypertension. Am Heart J 2007; 153: 127–132.